opioids

AMA Update 373: Understanding addiction and treating patients with substance use disorders with Bobby Mukkamala, MD

National Addiction Treatment Week kicks off today with Bobby Mukkamala, MD, chair of the AMA Substance Use and Pain Care Task Force, discussing the stigma of addiction, common barriers to substance abuse treatment, and physician advocacy efforts in the fight against the overdose epidemic in the U.S. Dr. Mukkamala also shares advice for doctors and practitioners on treating opioid use disorder and patients struggling with addiction. American Medical Association CXO Todd Unger hosts.

❤️‍🩹 2023 National Addiction Treatment Week is October 16-22, access resources at: http://www.treataddictionsavelives.org/

🥼 Learn more about the AMA Recovery Plan for America’s Physicians: https://bit.ly/AMA_RecoveryPlan

💪 Get involved in the fight to end the overdose epidemic: https://end-overdose-epidemic.org/

📨 Stay up to date on all the latest advocacy news by subscribing to AMA Advocacy Update: https://bit.ly/AMA_AdvocacyUpdate

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 351: The latest FDA naloxone approvals and Overdose Awareness Day with Bobby Mukkamala, MD

On International Overdose Awareness Day, Bobby Mukkamala, MD, chair of the AMA Substance Use and Pain Care Task Force, joins to discuss the current state of the overdose epidemic in the U.S. Dr. Mukkamala provides an update on over-the-counter naloxone approvals, offers advice for physicians and shares how the AMA is working to combat this crisis. American Medical Association CXO Todd Unger hosts.

🥼 Learn more about the AMA Recovery Plan for America’s Physicians: https://bit.ly/AMA_RecoveryPlan

💪 Get involved in the fight to end the overdose epidemic: https://end-overdose-epidemic.org/

📨 Stay up to date on all the latest advocacy news by subscribing to AMA Advocacy Update: https://bit.ly/AMA_AdvocacyUpdate

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 347: DEA opioid training requirements and the MATE Act explained with Sanjay Desai, MD

The MATE Act requires DEA-registered physicians to take eight hours of training on treating and managing patients with opioid or other substance use disorders. Sanjay Desai, MD, chief academic officer and group vice president of medical education at the American Medical Association, shares what doctors need to know and how to complete DEA license renewal. AMA CXO Todd Unger hosts.

💊 FAQs and the answer to «What is the MATE Act?», here: https://www.ama-assn.org/delivering-care/overdose-epidemic/what-mate-act

🎓 Access CME course «Substance Use Disorders and Addiction Education to Meet New DEA Requirements» at: https://edhub.ama-assn.org/course/302

📚 For more physician resources on how to comply with the MATE Act and DEA training requirements, visit AMA Ed Hub™: https://edhub.ama-assn.org/pages/comply-mate-act-dea-training-requirements

💪 Learn how the AMA is fighting to end the overdose epidemic: https://end-overdose-epidemic.org/

📨 Stay up to date on all the latest advocacy news by subscribing to AMA Advocacy Update: https://bit.ly/AMA_AdvocacyUpdate

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More